- Stocks
- Healthcare
- NASDAQ: INVA

Price (delayed)

$11.43

Market cap

$1.16B

P/E Ratio

5.17

Dividend/share

N/A

EPS

$2.21

Enterprise value

$1.3B

The equity has surged by 72% year-on-year and by 11% since the previous quarter

The stock's price to earnings (P/E) is 61% less than its 5-year quarterly average of 13.2 and 11% less than its last 4 quarters average of 5.8

Innoviva's quick ratio has plunged by 62% from the previous quarter and by 30% YoY

The debt has grown by 2.2% YoY

What are the main financial stats of INVA

Market
Valuations
Earnings

Shares outstanding

101.39M

Market cap

$1.16B

Enterprise value

$1.3B

Price to earnings (P/E)

5.17

Price to book (P/B)

2.15

Price to sales (P/S)

3.44

EV/EBIT

4.28

EV/EBITDA

4.09

EV/Sales

3.85

Revenue

$336.79M

EBIT

$303.16M

EBITDA

$317M

Free cash flow

$313.1M

Per share
Balance sheet
Liquidity

EPS

$2.21

Free cash flow per share

$3.09

Book value per share

$5.33

Revenue per share

$3.32

TBVPS

$9.87

Total assets

$999.57M

Total liabilities

$391.73M

Debt

$385.52M

Equity

$539.91M

Working capital

$335.95M

Debt to equity

0.71

Current ratio

55.98

Quick ratio

55.71

Net debt/EBITDA

0.44

Margins
Efficiency
Dividend

EBITDA margin

94.1%

Gross margin

100%

Net margin

66.6%

Operating margin

95.3%

Return on assets

25%

Return on equity

48.2%

Return on invested capital

33.6%

Return on capital employed

30.5%

Return on sales

90%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Innoviva stock price performed over time

Intraday

-1.64%

1 week

-2.64%

1 month

-8.63%

1 year

-16.57%

YTD

-7.75%

QTD

-7.75%

How have Innoviva's revenue and profit performed over time

Revenue

$336.79M

Gross profit

$336.79M

Operating income

$321.12M

Net income

$224.4M

Gross margin

100%

Net margin

66.6%

INVA's net income is up by 43% year-on-year and by 3.7% since the previous quarter

INVA's operating income is up by 30% YoY and by 3.6% QoQ

The gross profit is up by 29% YoY and by 4.5% from the previous quarter

The revenue has grown by 29% YoY and by 4.5% from the previous quarter

What is Innoviva's growth rate over time

What is Innoviva stock price valuation

P/E

5.17

P/B

2.15

P/S

3.44

EV/EBIT

4.28

EV/EBITDA

4.09

EV/Sales

3.85

The stock's price to earnings (P/E) is 61% less than its 5-year quarterly average of 13.2 and 11% less than its last 4 quarters average of 5.8

The company's EPS rose by 43% YoY and by 3.3% QoQ

The equity has surged by 72% year-on-year and by 11% since the previous quarter

The P/B is 20% below the last 4 quarters average of 2.7

The P/S is 54% lower than the 5-year quarterly average of 7.4 and 14% lower than the last 4 quarters average of 4.0

The revenue has grown by 29% YoY and by 4.5% from the previous quarter

How efficient is Innoviva business performance

The return on invested capital is up by 35% year-on-year but it has declined by 5% since the previous quarter

INVA's return on equity is down by 24% year-on-year and by 9% since the previous quarter

The company's return on sales rose by 8% YoY

INVA's ROA is up by 4.6% YoY but it is down by 4.2% from the previous quarter

What is INVA's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for INVA.

How did Innoviva financials performed over time

The total assets is 155% greater than the total liabilities

Innoviva's quick ratio has plunged by 62% from the previous quarter and by 30% YoY

The company's current ratio has shrunk by 62% QoQ and by 30% YoY

The debt is 29% less than the equity

The equity has surged by 72% year-on-year and by 11% since the previous quarter

The debt to equity has declined by 41% year-on-year and by 10% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.